[Necrotizing fasciitis, part 2 : Differential diagnoses of necrotizing fasciitis] [0.03%]
[坏死性筋膜炎，第二部分：坏死性筋膜炎的鉴别诊断]
Thomas Grieser
Thomas Grieser
Necrotizing fasciitis (NF) is known to be a potentially life-threatening bacterial infection of the deep fascias showing a tendency to rapid spread. For certain localizations (e.g., the scrotum or labia) of this disease, specific entities h...
Fabian Bauer,Thorsten Persigehl
Fabian Bauer
Background: With the increasing use of immune checkpoint inhibitors (ICI) and chimeric antigen receptor (CAR)-T cell therapies in modern oncology, immune-related adverse events (irAEs) are being observed more frequently, ...
[Side effects of immune checkpoint inhibitors : Focus on pulmonary events] [0.03%]
免疫检查点抑制剂的不良反应：关注肺部事件
Alexey Surov,Jan Borggrefe
Alexey Surov
The development of immune checkpoint inhibitors (ICI) has revolutionized cancer treatment. ICI enhance antitumor immunity by inhibiting the negative regulatory components of the T cell-mediated immune response against tumor cells. ICI are a...
[Cardiac side effects of immunotherapy : Role of imaging in immuno-oncology] [0.03%]
[免疫治疗的心脏不良反应：免疫肿瘤学中的影像作用]
Taraneh Aziz-Safaie,Lucia D Beissel,Annemarie Proff et al.
Taraneh Aziz-Safaie et al.
Background: Immunotherapies have become an integral part of modern oncology. Despite their therapeutic success, they are associated with cardiotoxic side effects that require early detection. Cardiac magnetic resonance im...
[Overview of immune checkpoint inhibitor therapy : What the radiologist should know] [0.03%]
免疫检查点抑制剂治疗概论——放射科医生需要了解什么？
Oliver Sedlaczek,Heinz-Peter Schlemmer
Oliver Sedlaczek
Clinical issue: In recent decades, oncology has been fundamentally transformed by immune checkpoint inhibitors (ICIs). By blocking inhibitory molecules that normally inhibit T cell activation, they reactivate the body's i...
Michael Winkelmann,Matthias Kassube,Philipp Linden et al.
Michael Winkelmann et al.
Clinical/methodical issue: Distinguishing pseudoprogression from true progression represents a considerable challenge in both clinical practice and radiological imaging. ...
[Overview of CAR-T cell therapy : What the radiologist should know] [0.03%]
嵌合抗原受体T细胞治疗概览——放射科医生应该了解什么
Mirjam Gerwing,Michel Eisenblätter
Mirjam Gerwing
Clinical issue: CAR-T cell therapy is complex and is now offered at a growing number of oncology centers in Germany. In addition to the initial CAR-T cell treatment, several advances and complementary therapies are availa...
[Imaging of neurological adverse events associated with immunotherapies : Immune checkpoint inhibitors and CAR-T cells] [0.03%]
[与免疫治疗相关的神经系统不良事件的影像学检查：免疫检查点抑制剂和CAR-T细胞]
Timotheus Josef Neumann,Anna Magdalena Baz,Elena Nicola Charlotte Schmidt et al.
Timotheus Josef Neumann et al.
Background: Immune checkpoint inhibitors (ICI) and chimeric antigen receptor T‑cell (CAR-T) therapies have fundamentally transformed oncology. With their increasing use, immune-related adverse events (irAEs) have gained ...
Sardi Hyska,Paul Reidler,Nina Hesse
Sardi Hyska
Background: Bone infarctions are a relatively understudied subgroup of osteonecroses in the literature. As frequently incidental, yet distinct imaging findings, they must be interpreted in the context of predisposed patie...
Yannik Leonhardt,Klaus Wörtler
Yannik Leonhardt
Avascular necrosis of the femoral head (AVN) describes an ischemia-induced necrosis of the subchondral bone of the femoral head. Early diagnosis is crucial to initiate appropriate treatment and achieve the longest possible preservation of t...